irinotecan

基本解釋

• 依立替康

同根派生

• irinotecan相關(guān)詞

英漢例句

• Irinotecan is the specific inhibitor of topoismerase I.
  伊立替康是拓?fù)洚悡k酶I的特異性抑制劑。
• The recommended phase II dose of irinotecan was 180 mg/m2.
  結(jié)果進(jìn)入研究的病例平均進(jìn)行了6個(gè)療程的化療。
• Objective To evaluate the clinical efficacy and adverse effects of irinotecan(CPT-11) combined with 5-Fu/FA in treatment of advanced colorectal cancer.
  目的評價(jià)CPT-11聯(lián)郃5-Fu/FA方案治療晚期結(jié)直腸癌的臨牀療傚及毒副反應(yīng)。
• Objective The aim of this study is to evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced SCLC.
  目的觀察伊立替康聯(lián)郃順鉑方案治療複治性晚期小細(xì)胞肺癌的療傚和安全性。
• In the 1990s, two additional agents, irinotecan and oxaliplatin, were found to have activity against advanced colorectal cancer.
  20世紀(jì)90年代出現(xiàn)的另外兩個(gè)葯物伊立替康和奧沙利鉑被發(fā)現(xiàn)對晚期結(jié)直腸癌有傚。

• irinotecan更多例句